SM
LLY icon

Stephen Mandel’s Eli Lilly LLY Stock Holding History

Stephen Mandel’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-551,827
Closed -$456M – 27
2025
Q1 		$456M Sell
551,827
-231,033
-30% -$192M 3.94% 15
2024
Q4 		$604M Buy
+782,860
New +$648M 4.49% 9

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Stephen Mandel's LLY Position: Q2 2025 in Review

Stephen Mandel sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 551,827 shares — an estimated $456M sold.

Stephen Mandel first reported a position in LLY in Q4 2024 and held it in 2 quarters. The position peaked at $604M in Q4 2024. 3,913 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Stephen Mandel reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Stephen Mandel sold 551,827 Eli Lilly shares in Q2 2025, an estimated $456M.
  • Stephen Mandel first reported a position in Eli Lilly in Q4 2024 and held it in 2 quarters.
  • Stephen Mandel's Eli Lilly position peaked at $604M in Q4 2024.
  • 3,913 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Lone Pine Capital's 13F filing for Q2 2025, filed 14 Aug 2025.